Esperion Therapeutics, Inc.·4

Jun 16, 4:07 PM ET

VITULLO NICOLE 4

4 · Esperion Therapeutics, Inc. · Filed Jun 16, 2023

Insider Transaction Report

Form 4
Period: 2023-06-15
VITULLO NICOLE
Director10% Owner
Transactions
  • Award

    Common Stock

    2023-06-15+5,15036,918 total
  • Award

    Stock Option (right to buy)

    2023-06-15+21,00021,000 total
    Exercise: $1.37Exp: 2033-06-15Common Stock (21,000 underlying)
Footnotes (1)
  • [F1]The awards vest in full on the earlier of (i) June 15, 2024 and (ii) the Issuer's next annual meeting of stockholders following June 15, 2023.

Documents

2 files
  • 4
    wf-form4_168694602658326.xmlPrimary

    FORM 4

  • EX-24

    VITULLO POA